Drug
pimavanserin tartrate
Marketed as NUPLAZID.
Generic name
pimavanserin tartrate
Brand names
NUPLAZID
First FDA approval
2016-04-29
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA210793 | NUPLAZID | 2018-06-28 | ACADIA PHARMS INC |
| NDA207318 | NUPLAZID | 2016-04-29 | ACADIA PHARMS INC |
Manufacturers
ACADIA PHARMS INC
Frequently asked questions
When was pimavanserin tartrate FDA approved?
Earliest FDA approval on record: 2016-04-29.
What brand names are sold as pimavanserin tartrate?
NUPLAZID.
Sources
Appeal a pimavanserin tartrate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com